mrjСовременная ревматологияModern Rheumatology Journal1996-70122310-158XIMA-PRESS, LLC10.14412/1996-7012-2021-2-77-82mrj-1126Research ArticleКЛИНИЧЕСКИЕ НАБЛЮДЕНИЯCLINICAL OBSERVATIONSСклеродерма-панникулит: взгляд ревматологаScleroderma-panniculitis: view of the rheumatologisthttps://orcid.org/0000-0002-8627-5341ПотаповаА. С.PotapovaA. S.

Алена Сергеевна Потапова

115522, Москва, Каширское шоссе, 34А

 

 

Alena Sergeevna Potapova

34A, Kashirskoe Shosse, Moscow 115522

dr.aspotapova@gmail.comhttps://orcid.org/0000-0002-4846-5531ЕгороваО. Н.EgorovaO. N.

115522, Москва, Каширское шоссе, 34А

34A, Kashirskoe Shosse, Moscow 115522

https://orcid.org/0000-0003-1852-1798АлексееваО. Г.AlekseevaO. G.

115522, Москва, Каширское шоссе, 34А

34A, Kashirskoe Shosse, Moscow 115522

https://orcid.org/0000-0003-1784-3699ВолковА. В.VolkovA. V.

115522, Москва, Каширское шоссе, 34А

34A, Kashirskoe Shosse, Moscow 115522

https://orcid.org/0000-0002-1084-3920КудинскийД. М.KudinskyD. M.

115522, Москва, Каширское шоссе, 34А

34A, Kashirskoe Shosse, Moscow 115522

ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»РоссияV.A. Nasonova Research Institute of RheumatologyRussian Federation2021230420211527782Copyright © Потапова А.С., Егорова О.Н., Алексеева О.Г., Волков А.В., Кудинский Д.М., 20212021Потапова А.С., Егорова О.Н., Алексеева О.Г., Волков А.В., Кудинский Д.М.Potapova A.S., Egorova O.N., Alekseeva O.G., Volkov A.V., Kudinsky D.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://mrj.ima-press.net/mrj/article/view/1126

В статье обсуждаются трудности диагностики и терапии склеродермы-панникулита (С-Пн), одного из вариантов септального Пн. Рассматривается целесообразность использования УЗИ, магнитно-резонансной томографии мягких тканей и гистологического исследования уплотнений с целью своевременного выявления Пн. Представлено клиническое наблюдение сочетания С-Пн и антифосфолипидного синдрома.

Difficulties in diagnosis and therapy of scleroderma-panniculitis (S-PN), one of the variants of the septal PN, are discussed. Feasibility of ultrasonography, magnetic resonance imaging of soft tissues and histological examination of the lesions in order to set the diagnosis of PN in time is considered. The clinical case of S-PN combined with antiphospholipid syndrome is presented.

панникулитсклеродерма-панникулитантифосфолипидный синдромдиагностикалечениеscleroderma-panniculitisantiphospholipid syndromediagnosticstreatmentReferencesЕгорова ОН, Белов БС. Панникулиты в практике дерматовенеролога и интерниста. Consilium Medicum. 2020;22(7):78-83.Egorova ON, Belov BS. Panniculitis in the practice of a dermatovenerologist and internist. Consilium Medicum. 2020;22(7):7 8-83. (In Russ.).Wick MR. Panniculitis: а summary. Semin Diagn Pathol. 2017 May;34(3):261-72. doi: 10.1053/j.semdp.2016.12.004. Epub 2016 Dec 27.Wick MR. Panniculitis: а summary. Semin Diagn Pathol. 2017 May;34(3):261-72. doi: 10.1053/j.semdp.2016.12.004. Epub 2016 Dec 27.Caputo V, Rongioletti F. Panniculitis in the setting of dermato/rheumatologic diseases. G Ital Dermatol Venereol. 2018 Apr;153(2): 194-207. doi: 10.23736/S0392-0488.17.05845-X. Epub 2017 Dec 15.Caputo V, Rongioletti F. Panniculitis in the setting of dermato/rheumatologic diseases. G Ital Dermatol Venereol. 2018 Apr;153(2): 194-207. doi: 10.23736/S0392-0488.17.05845-X. Epub 2017 Dec 15.Requena L, Yus ES. Panniculitis. Part I. Mostly septal panniculitis. J Am Acad Dermatol. 2001 Aug;45(2):163-83; quiz 184-6. doi: 10.1067/mjd.2001.114736.Requena L, Yus ES. Panniculitis. Part I. Mostly septal panniculitis. J Am Acad Dermatol. 2001 Aug;45(2):163-83; quiz 184-6. doi: 10.1067/mjd.2001.114736.Requena L, Yus ES. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol. 2001 Sep;45(3):325-61; quiz 362-4. doi: 10.1067/mjd.2001.114735.Requena L, Yus ES. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol. 2001 Sep;45(3):325-61; quiz 362-4. doi: 10.1067/mjd.2001.114735.Раденска-Лоповок СГ, Егорова ОН, Белов БС и др. Идиопатический лобулярный панникулит: клинико-морфологические корреляции. Архив патологии. 2019;81(3):37-44.Radenska-Lopovok SG, Egorova ON, Belov BS, et al. Idiopathic lobular panniculitis: clinical and morphological correlations. Arkhiv patologii. 2019;81(3):37-44. (In Russ.).Bö er-Auer A. Differenzialdiagnostik der Pannikulitis. Hautarzt. 2016 Jul;67(7):555-69. doi: 10.1007/s00105-016-3794-2.Bö er-Auer A. Differenzialdiagnostik der Pannikulitis. Hautarzt. 2016 Jul;67(7):555-69. doi: 10.1007/s00105-016-3794-2.Peterson LS, Nelson AM, Su WP, et al. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-93. J Rheumatol. 1997 Jan;24(1):73-80.Peterson LS, Nelson AM, Su WP, et al. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-93. J Rheumatol. 1997 Jan;24(1):73-80.Lafyatis R., Farina V. New understanding of the mechanisms of innate immunity receptor signaling in fibrosis. Open Rheumatol J. 2012;6:72-9. doi: 10.2174/1874312901206010072. Epub 2012 Jun 15.Lafyatis R., Farina V. New understanding of the mechanisms of innate immunity receptor signaling in fibrosis. Open Rheumatol J. 2012;6:72-9. doi: 10.2174/1874312901206010072. Epub 2012 Jun 15.Badea I, Taylor M, Rosenberg A, Foldvari M. Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis. Rheumatology (Oxford). 2009 Mar;48(3): 213-21. doi: 10.1093/rheumatology/ken405. Epub 2008 Nov 20.Badea I, Taylor M, Rosenberg A, Foldvari M. Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis. Rheumatology (Oxford). 2009 Mar;48(3): 213-21. doi: 10.1093/rheumatology/ken405. Epub 2008 Nov 20.Zulian F, Vallongo C, Woo P, et al. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum. 2005 Sep; 52(9):2873-81. doi: 10.1002/art.21264.Zulian F, Vallongo C, Woo P, et al. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum. 2005 Sep; 52(9):2873-81. doi: 10.1002/art.21264.Романова НВ. Иммунопатологические нарушения и цитокиновый профиль при системной и ограниченной склеродермии.Терапевтический архив. 2012;(5):28-31.Romanova NV. Immunopathological disorders and cytokine profile in systemic and limited scleroderma. Terapevticheskii arkhiv. 2012;(5):28-31. (In Russ.).Li SC. Scleroderma in children and adolescents: localized scleroderma and systemic sclerosis. Pediatr Clin North Am. 2018 Aug; 65(4):757-81. doi: 10.1016/j.pcl.2018.04.002.Li SC. Scleroderma in children and adolescents: localized scleroderma and systemic sclerosis. Pediatr Clin North Am. 2018 Aug; 65(4):757-81. doi: 10.1016/j.pcl.2018.04.002.Scalapino K, Arkaschaisri T, Lucas M, et al. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol. 2006 May;33(5): 1004-13. Epub 2006 Apr 1.Scalapino K, Arkaschaisri T, Lucas M, et al. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol. 2006 May;33(5): 1004-13. Epub 2006 Apr 1.George R, George A, Kumar TS. Update on management of Morphea (Localized Scleroderma) in childrenIndian. Indian Dermatol Online J. 2020 Mar 9;11(2):135-45. doi: 10.4103/idoj.IDOJ_284_19. eCollection Mar-Apr 2020.George R, George A, Kumar TS. Update on management of Morphea (Localized Scleroderma) in childrenIndian. Indian Dermatol Online J. 2020 Mar 9;11(2):135-45. doi: 10.4103/idoj.IDOJ_284_19. eCollection Mar-Apr 2020.Careta MF, Romiti R. Localized scleroderma: Clinical spectrum and therapeutic update. An Bras Dermatol. Jan-Feb 2015; 90(1):62-73. doi: 10.1590/abd1806-4841.20152890.Careta MF, Romiti R. Localized scleroderma: Clinical spectrum and therapeutic update. An Bras Dermatol. Jan-Feb 2015; 90(1):62-73. doi: 10.1590/abd1806-4841.20152890.Lis-Swiety А, Brzezinska-Wcislo L, Arasiewicz Н, Bergler-Czop В. Antiphospholipid antibodies in localized scleroderma: the potential role of screening tests for the detection of antiphospholipid syndrome. Postepy Dermatol Alergol. 2014 May; 31(2):65-70. doi: 10.5114/pdia.2014.40978. Epub 2014 AprLis-Swiety А, Brzezinska-Wcislo L, Arasiewicz Н, Bergler-Czop В. Antiphospholipid antibodies in localized scleroderma: the potential role of screening tests for the detection of antiphospholipid syndrome. Postepy Dermatol Alergol. 2014 May; 31(2):65-70. doi: 10.5114/pdia.2014.40978. Epub 2014 Apr18. Hunt RD, Robinson М, Patel R, Franks AG. Antiphospholipid-antibody-associated panniculitis. Dermatol Online J. 2012 Dec 15;18(12):18.18. Hunt RD, Robinson М, Patel R, Franks AG. Antiphospholipid-antibody-associated panniculitis. Dermatol Online J. 2012 Dec 15;18(12):18.Renfro L, Franks AG, Grodberg M, Kamino H. Painful nodules in a young female: antiphospholipid syndrome. Arch Dermatol. 1992 Jun;128(6):847-8, 850-1. doi: 10.1001/archderm.1992.01680160133022.Renfro L, Franks AG, Grodberg M, Kamino H. Painful nodules in a young female: antiphospholipid syndrome. Arch Dermatol. 1992 Jun;128(6):847-8, 850-1. doi: 10.1001/archderm.1992.01680160133022.Jimenez-Mazuecos J, Yebra-Bango M, Sanchez-Ruiz A, Villarreal-Garcia-Lomas M. Weber-Christian disease associated with lupus anticoagulant and anticardiolipin antibodies. Rheumatology (Oxford). 1999 Aug; 38(8):796-7. doi: 10.1093/rheumatology/38.8.796.Jimenez-Mazuecos J, Yebra-Bango M, Sanchez-Ruiz A, Villarreal-Garcia-Lomas M. Weber-Christian disease associated with lupus anticoagulant and anticardiolipin antibodies. Rheumatology (Oxford). 1999 Aug; 38(8):796-7. doi: 10.1093/rheumatology/38.8.796.Torok КS, Li SС, Jacobe НМ, et al. Immunopathogenesis of Pediatric Localized Scleroderma. Front Immunol. 2019 Apr 30; 10:908. doi: 10.3389/fimmu.2019.00908. eCollection 2019.Torok КS, Li SС, Jacobe НМ, et al. Immunopathogenesis of Pediatric Localized Scleroderma. Front Immunol. 2019 Apr 30; 10:908. doi: 10.3389/fimmu.2019.00908. eCollection 2019.Weibel L, Laguda B, Atherton D, Harper JI. Misdiagnosis and delay in referral of children with localized scleroderma. Br J Dermatol. 2011 Dec;165(6):1308-13. doi: 10.1111/j.1365-2133.2011.10600.x. Epub 2011 Nov 2.Weibel L, Laguda B, Atherton D, Harper JI. Misdiagnosis and delay in referral of children with localized scleroderma. Br J Dermatol. 2011 Dec;165(6):1308-13. doi: 10.1111/j.1365-2133.2011.10600.x. Epub 2011 Nov 2.Wu EY, Li SC, Torok KS, et al. Baseline description of the juvenile localized scleroderma subgroup from the childhood arthritis and rheumatology research alliance legacy registry. ACR Open Rheumatol. 2019 Apr 10; 1(2):119-24. doi: 10.1002/acr2.1019. eCollection 2019 Apr.Wu EY, Li SC, Torok KS, et al. Baseline description of the juvenile localized scleroderma subgroup from the childhood arthritis and rheumatology research alliance legacy registry. ACR Open Rheumatol. 2019 Apr 10; 1(2):119-24. doi: 10.1002/acr2.1019. eCollection 2019 Apr.Li SC, Li X, Pope E, et al. New Features for Measuring Disease Activity in Pediatric Localized Scleroderma. J Rheumatol. 2018 Dec;45(12):1680-8. doi: 10.3899/jrheum.171381. Epub 2018 SepLi SC, Li X, Pope E, et al. New Features for Measuring Disease Activity in Pediatric Localized Scleroderma. J Rheumatol. 2018 Dec;45(12):1680-8. doi: 10.3899/jrheum.171381. Epub 2018 Sep25. Schoch J, Schoch B, Davis D. Orthopedic complications of linear morphea: Implications for early interdisciplinary care. Pediatr Dermatol. 2018 Jan;35(1):43-6. doi: 10.1111/pde.13336. Epub 2017 Nov 9.25. Schoch J, Schoch B, Davis D. Orthopedic complications of linear morphea: Implications for early interdisciplinary care. Pediatr Dermatol. 2018 Jan;35(1):43-6. doi: 10.1111/pde.13336. Epub 2017 Nov 9.Kimball H, Kimball D, Siroy A, et al. Novel diagnostic imaging features of facial lupus panniculitis: ultrasound, CT, and MR imaging with histopathology correlate. Clin Imaging. Nov-Dec 2019;58:177-81. doi: 10.1016/j.clinimag.2019.07.006. Epub 2019 Jul 23.Kimball H, Kimball D, Siroy A, et al. Novel diagnostic imaging features of facial lupus panniculitis: ultrasound, CT, and MR imaging with histopathology correlate. Clin Imaging. Nov-Dec 2019;58:177-81. doi: 10.1016/j.clinimag.2019.07.006. Epub 2019 Jul 23.Hemmi S, Kushida R, Nishimura H, et al. Magnetic resonance imaging diagnosis of panniculitis in dermatomyositis. Muscle Nerve. 2010 Jan;41(1):151-3. doi: 10.1002/mus.21537.Hemmi S, Kushida R, Nishimura H, et al. Magnetic resonance imaging diagnosis of panniculitis in dermatomyositis. Muscle Nerve. 2010 Jan;41(1):151-3. doi: 10.1002/mus.21537.Romani J, Giavedoni P, Roe E, et al. Inter- and Intra-rater Agreement of Dermatologic Ultrasound for the Diagnosis of Lobular and Septal Panniculitis. J Ultrasound Med. 2020 Jan;39(1):107-12. doi: 10.1002/jum.15080. Epub 2019 Jun 27.Romani J, Giavedoni P, Roe E, et al. Inter- and Intra-rater Agreement of Dermatologic Ultrasound for the Diagnosis of Lobular and Septal Panniculitis. J Ultrasound Med. 2020 Jan;39(1):107-12. doi: 10.1002/jum.15080. Epub 2019 Jun 27.Cid PM, Flores CR, Caelles IP, et al. High-frequency ultrasound features in a case of gouty panniculitis. Dermatol Online J. 2017 Jun 15;23(6):13030/qt33j2z14m.Cid PM, Flores CR, Caelles IP, et al. High-frequency ultrasound features in a case of gouty panniculitis. Dermatol Online J. 2017 Jun 15;23(6):13030/qt33j2z14m.Егорова ОН, Белов БС. Панникулиты: ревматологические аспекты. Современная ревматология. 2018;12(2):73-8. doi: 10/14412/1996-7012-2018-2-73-78.Egorova ON, Belov BS. Panniculitis: rheumatological aspects. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2018;12(2):73-8. (In Russ.). doi: 10/14412/1996-7012-2018-2-73-78.Narbutt J, Holdrowicz A, Lesiak A. Morphea – Selected local treatment methods and their effectiveness. Reumatologia. 2017; 55(6):305-13. doi: 10.5114/reum.2017.72628. Epub 2017 Dec 30.Narbutt J, Holdrowicz A, Lesiak A. Morphea – Selected local treatment methods and their effectiveness. Reumatologia. 2017; 55(6):305-13. doi: 10.5114/reum.2017.72628. Epub 2017 Dec 30.Dytoc MT, Kossintseva I, Ting PT. First case series on the use of calcipotriolbetamethasone dipropionate for morphoea. Br J Dermatol. 2007 Sep;157(3):615-8. doi: 10.1111/j.1365-2133.2007.07971.x. Epub 2007 Jun 6.Dytoc MT, Kossintseva I, Ting PT. First case series on the use of calcipotriolbetamethasone dipropionate for morphoea. Br J Dermatol. 2007 Sep;157(3):615-8. doi: 10.1111/j.1365-2133.2007.07971.x. Epub 2007 Jun 6.Koch SB, Cerci FB, Jorizzo JL, Krowchuk DP. Linear morphea: A case series with long-term follow-up of young, methotrexate-treated patients. J Dermatolog Treat. 2013 Dec;24(6):435-8. doi: 10.3109/09546634.2013.806769. Epub 2013 Jul 15.Koch SB, Cerci FB, Jorizzo JL, Krowchuk DP. Linear morphea: A case series with long-term follow-up of young, methotrexate-treated patients. J Dermatolog Treat. 2013 Dec;24(6):435-8. doi: 10.3109/09546634.2013.806769. Epub 2013 Jul 15.Martini G, Ramanan AV, Falcini F, et al. Successful treatment of severe or methotrexateresistant juvenile localized scleroderma with mycophenolate mofetil. Rheumatology (Oxford). 2009 Nov;48(11):1410-3. doi: 10.1093/rheumatology/kep244. Epub 2009 Aug 27.Martini G, Ramanan AV, Falcini F, et al. Successful treatment of severe or methotrexateresistant juvenile localized scleroderma with mycophenolate mofetil. Rheumatology (Oxford). 2009 Nov;48(11):1410-3. doi: 10.1093/rheumatology/kep244. Epub 2009 Aug 27.Kumar AB, Blixt EK, Drage LA, et al. Treatment of morphea with hydroxychloroquine: A retrospective review of 84 patients at Mayo Clinic, 1996-2013. J Am Acad Dermatol. 2019 Jun;80(6):1658-63. doi: 10.1016/j.jaad.2019.01.040. Epub 2019 Jan 29.Kumar AB, Blixt EK, Drage LA, et al. Treatment of morphea with hydroxychloroquine: A retrospective review of 84 patients at Mayo Clinic, 1996-2013. J Am Acad Dermatol. 2019 Jun;80(6):1658-63. doi: 10.1016/j.jaad.2019.01.040. Epub 2019 Jan 29.Bali G1, Frü hauf J, Wutte N, Aberer E. Cyclosporine reduces sclerosis in morphea: A retrospective study in 12 patients and a literature review. Dermatology. 2016;232(4): 503-10. doi: 10.1159/000448171. Epub 2016 Aug 30.Bali G1, Frü hauf J, Wutte N, Aberer E. Cyclosporine reduces sclerosis in morphea: A retrospective study in 12 patients and a literature review. Dermatology. 2016;232(4): 503-10. doi: 10.1159/000448171. Epub 2016 Aug 30.Zhang A, Nocton J, Chiu Y. A case of pansclerotic morphea treated with tocilizumab. JAMA Dermatol. 2019 Mar 1;155(3): 388-9. doi: 10.1001/jamadermatol.2018.5040.Zhang A, Nocton J, Chiu Y. A case of pansclerotic morphea treated with tocilizumab. JAMA Dermatol. 2019 Mar 1;155(3): 388-9. doi: 10.1001/jamadermatol.2018.5040.Kim SR, Charos A, Damsky W, et al. Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib. JAAD Case Rep. 2018 Apr 30;4(5):443-5. doi: 10.1016/j.jdcr.2017.12.003. eCollection 2018 Jun.Kim SR, Charos A, Damsky W, et al. Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib. JAAD Case Rep. 2018 Apr 30;4(5):443-5. doi: 10.1016/j.jdcr.2017.12.003. eCollection 2018 Jun.

The authors declare that there are no conflicts of interest present.